Nvidia Stock Options Stay Hot Ahead of Earnings Event — Neutral
NVDA Schaeffers Research — November 17, 2025With tech valuation concerns running rampant, it's no surprise that Nvidia Corp's (NASDAQ:NVDA) third-quarter earnings report is one of the most highly-anticipated events of the week.
TD Cowen analyst Joshua Buchalter has reaffirmed his bullish stance on Advanced Micro Devices (NASDAQ: AMD), reiterating a ‘Buy' rating and maintaining a $290 price target.
Primo Brands Corporation (PRMB) Faces Securities Class Action Amid Botched Integration, CEO Departure – Hagens Berman — Neutral
PRMB GlobeNewsWire — November 17, 2025SAN FRANCISCO, Nov. 17, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit has been filed against beverage company Primo Brands Corporation (NYSE: PRMB) in the wake of its troubled merger with BlueTriton Brands. The suit seeks to represent investors who purchased or otherwise acquired the common stock of Primo Water between June 17, 2024 and November 8, 2024.
lululemon Eyes Asia Business for Expansion: Will It Move the Needle? — Positive
LULU Zacks Investment Research — November 17, 2025LULU leans on fast-growing Asia momentum, with China powering Q2 gains as the brand doubles down on expansion to lift global results.
Is Crocs' Innovation Pipeline Strong Enough to Fuel Future Growth? — Positive
CROX Zacks Investment Research — November 17, 2025CROX leans on bold innovation, new franchises, and standout sandal momentum to fuel global demand and drive long-term growth.
Is the Options Market Predicting a Spike in SSB Stock? — Neutral
SSB Zacks Investment Research — November 17, 2025Investors need to pay close attention to SouthState Bank stock based on the movements in the options market lately.
3 Reasons Growth Investors Will Love Comfort Systems (FIX) — Positive
FIX Zacks Investment Research — November 17, 2025Comfort Systems (FIX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Here is Why Growth Investors Should Buy OppFi (OPFI) Now — Positive
OPFI Zacks Investment Research — November 17, 2025OppFi (OPFI) possesses solid growth attributes, which could help it handily outperform the market.
Here is Why Growth Investors Should Buy Northrim (NRIM) Now — Positive
NRIM Zacks Investment Research — November 17, 2025Northrim (NRIM) possesses solid growth attributes, which could help it handily outperform the market.
3 Reasons Growth Investors Will Love HCI Group (HCI) — Positive
HCI Zacks Investment Research — November 17, 2025HCI Group (HCI) possesses solid growth attributes, which could help it handily outperform the market.
3 Reasons Why Growth Investors Shouldn't Overlook Kaiser (KALU) — Positive
KALU Zacks Investment Research — November 17, 2025Kaiser (KALU) could produce exceptional returns because of its solid growth attributes.
Is Amazon (AMZN) a Solid Growth Stock? 3 Reasons to Think "Yes" — Positive
AMZN Zacks Investment Research — November 17, 2025Amazon (AMZN) possesses solid growth attributes, which could help it handily outperform the market.
Alphabet (GOOG) is an Incredible Growth Stock: 3 Reasons Why — Positive
GOOG GOOGL Zacks Investment Research — November 17, 2025Alphabet (GOOG) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Looking for a Growth Stock? 3 Reasons Why WisdomTree, Inc. (WT) is a Solid Choice — Positive
WT Zacks Investment Research — November 17, 2025WisdomTree, Inc. (WT) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Here is Why Growth Investors Should Buy Alphabet (GOOGL) Now — Positive
GOOG GOOGL Zacks Investment Research — November 17, 2025Alphabet (GOOGL) possesses solid growth attributes, which could help it handily outperform the market.
Will Nvidia Stock Rally After Its Q3 Earnings Report? — Positive
NVDA Investors Business Daily — November 17, 2025Analysts are wondering if Nvidia CEO Jensen Huang can say anything that will drive Nvidia stock higher after its Q3 report.
Zymeworks Surges On Positive Ziihera Phase 3 Data: Expanding First-Line GEA Opportunity — Positive
ZYME Seeking Alpha — November 17, 2025Zymeworks Inc. (ZYME) surged after positive Phase 3 results for Ziihera in first-line HER2-positive gastroesophageal adenocarcinoma, expanding its FDA-approved indications. ZYME's partnership-driven model, strong cash position, and milestone revenues limit capital risk and provide a projected runway into 2H27. The positive Ziihera data supports regulatory submission in 2026, with key catalysts including full data presentation and sBLA filing, and potential label expansion.
CarMax, Inc. (KMX) Investors: January 2, 2026 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP — Neutral
KMX PRNewsWire — November 17, 2025RADNOR, Pa. , Nov. 17, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that an amended securities class action lawsuit has been filed against CarMax, Inc. ("CarMax") (NYSE: KMX) which expands the class period to include those who purchased or otherwise acquired CarMax securities between June 20, 2025, and November 5, 2025, inclusive (the "Class Period").
U.S. Investigators Probe Exec Facing Fraud Allegations From BlackRock's HPS — Negative
BLK WSJ — November 17, 2025Federal officials have opened a criminal investigation into Bankim Brahmbhatt, who was sued by HPS and other lenders earlier this year.
CYTK DEADLINE: ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important November 17 Deadline in Securities Class Action - CYTK — Neutral
CYTK Newsfile Corp — November 17, 2025New York, New York--(Newsfile Corp. - November 17, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cytokinetics, Inc. (NASDAQ: CYTK) between December 27, 2023 and May 6, 2025, both dates inclusive (the "Class Period"), of the important November 17, 2025 lead plaintiff deadline. SO WHAT: If you purchased Cytokinetics common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
